ArticleFrontiers in medicine2026
Altered lipid profile in uterine leiomyoma: a focus on apolipoprotein A1 reduction and machine learning-based predictive modeling.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the association between uterine leiomyomas (UL) and specific alterations in serum lipid profiles, and to evaluate the performance of machine learning models incorporating these markers for UL discrimination. Methods: In this age- and body mass index matched case-control study, 200 patients with histologically confirmed UL and 200 controls with normal uteri were enrolled. Fasting serum levels of total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, apolipoprotein A1 (ApoA1), and apolipoprotein B were measured. Logistic regression identified independent risk factors, which were then used to construct predictive models via several machine learning algorithms. Model performance was assessed using receiver operating characteristic curve analysis. Results: Patients with UL exhibited significantly lower serum levels of triglycerides and ApoA1 compared to controls. Multivariate analysis confirmed lower triglyceride and ApoA1 levels, along with higher gravidity and premenopausal status, as independent factors associated with UL. While individual lipid parameters showed limited discriminative power, integrative models combining these with clinical features achieved high performance. The Random Forest model demonstrated superior discriminative ability, with an area under the curve of 0.986. Conclusion: After rigorous confounding control, UL is independently associated with a distinct metabolic phenotype characterized by reduced serum triglyceride and ApoA1 levels. Prediction models integrating these lipid abnormalities with clinical data show promising potential for risk assessment, highlighting a unique interplay between lipid metabolism and UL pathogenesis worthy of further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.